Screener
Sarepta Therapeutics, Inc. SRPT Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Sarepta Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
FAQ
- What is Sarepta Therapeutics, Inc.'s current ratio?
- Sarepta Therapeutics, Inc. (SRPT) reported current ratio of 4.4× in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s current ratio changed year-over-year?
- Sarepta Therapeutics, Inc.'s current ratio increased by 53.1% year-over-year, from 2.9× to 4.4×.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s current ratio has grown at a -17.3% compound annual growth rate (CAGR), from 6× to 2.3×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Sarepta Therapeutics, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude